Effect of enzyme replacement therapy on the growth of patients with Morquio syndrome type A

被引:1
|
作者
Tomatsu, Shunji [1 ]
Doherty, Caitlin [1 ]
Stapleton, Molly [1 ]
机构
[1] Nemours Alfred I duPont Hosp Children, Wilmington, DE USA
关键词
D O I
10.1016/j.ymgme.2018.12.371
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
355
引用
收藏
页码:S144 / S144
页数:1
相关论文
共 50 条
  • [21] Clinical outcomes in elderly patients with Morquio a syndrome receiving enzyme replacement therapy - experience in a Colombian center
    Felipe Erazo-Narvaez, Andres
    Manuel Munoz-Vidal, Juan
    Hernando Rodriguez-Velez, Guillermo
    Amparo Acosta-Aragon, Maria
    MOLECULAR GENETICS AND METABOLISM REPORTS, 2020, 25
  • [22] Enzyme Replacement Therapy with Elosulfase alfa for Mucopolysaccharidosis IVA (Morquio A Syndrome): Milestones and Challenges
    Puckett, Yana
    Mulinder, Holly
    Montano, Adriana M.
    EXPERT OPINION ON ORPHAN DRUGS, 2017, 5 (09): : 741 - 752
  • [23] Immunogenicity of elosulfase alfa, an enzyme replacement therapy in patients with Morquio syndrome type A: Results from MOR-004, a phase 3 trial
    Schweighardt, Becky
    Tompkins, Troy
    Lau, Kelly
    Jesaitus, Lynne
    Qi, Yulan
    Musson, Donald G.
    Farmer, Pamela
    Haller, Christine
    Shaywitz, Adam J.
    Yang, Ke
    O'Neill, Charles A.
    MOLECULAR GENETICS AND METABOLISM, 2015, 114 (02) : S105 - S105
  • [24] Towards the development of a less immunogenic protein for enzyme replacement therapy of Morquio disease type A
    Sosa-Molano, Angela
    Montano, Adriana
    MOLECULAR GENETICS AND METABOLISM, 2013, 108 (02) : S87 - S87
  • [25] Impact of Enzyme Replacement Therapy on Linear Growth in Korean Patients with Mucopolysaccharidosis Type II (Hunter Syndrome)
    Cho, Sung Yoon
    Huh, Rimm
    Chang, Mi Sun
    Lee, Jieun
    Kwun, Younghee
    Maeng, Se Hyun
    Kim, Su Jin
    Sohn, Young Bae
    Park, Sung Won
    Kwon, Eun-Kyung
    Han, Sun Ju
    Jung, Jooyoun
    Jin, Dong-Kyu
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2014, 29 (02) : 254 - 260
  • [26] Growth in patients with mucopolysaccharidosis type II receiving enzyme replacement therapy
    Schulze-Frenking, G.
    Wendt, S.
    Mengel, E.
    Beck, M.
    ACTA PAEDIATRICA, 2008, 97 : 100 - 100
  • [27] Effects of enzyme replacement therapy on growth in patients with mucopolysaccharidosis type II
    Schulze-Frenking, G.
    Jones, Simon A.
    Roberts, J.
    Beck, M.
    Wraith, J. E.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2011, 34 (01) : 203 - 208
  • [28] ENZYME REPLACEMENT THERAPY: A CASE OF SUCCESSFUL ELOSULFASE ALFA DESENSITIZATION IN A MORQUIO A SYNDROME PATIENT.
    CaJacob, A.
    Adkins, C.
    Descartes, M.
    Allen, C.
    Anderson, J.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2014, 113 (05) : A25 - A26
  • [29] Effect of enzyme replacement therapy on airway abnormalities in patients with Hunter syndrome
    Wood, Robert E.
    Hopkin, Robert
    Wehmeyer, Connie
    Bailey, Laurie
    MOLECULAR GENETICS AND METABOLISM, 2015, 114 (02) : S127 - S127
  • [30] The effect of galsulfase enzyme replacement therapy on the growth of patients with mucopolysaccharidosis VI (Maroteaux-Lamy syndrome)
    Harmatz, P.
    Hendriksz, C. J.
    Lampe, C.
    McGill, J. J.
    Parini, R.
    Leao-Teles, E.
    Valayannopoulos, V.
    Cole, Tj.
    Matousek, R.
    Graham, S.
    Guffon, N.
    Quartel, A.
    MOLECULAR GENETICS AND METABOLISM, 2017, 122 (1-2) : 107 - 112